MedTrace Logo

Impact of Clinical Ultrasound in Patients With Heart Failure Treated in Home Hospitalization

NCT05042752 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2021-09-29

No results posted yet for this study

Summary

The purpose of this study is to assess whether clinical ultrasound (CU)-guided treatment in acute heart failure (AHF) is superior to the standard care (SC)-guided treatment. We would like to see if using a portable ultrasound to guide diuretic therapy for AHF patients will prevent hospital readmissions in the setting of hospitalization at home (HAH). This study will use a handheld ultrasound called IVIZ-Sonosite and aims to see whether changing diuretic therapy based on the performance of the ultrasound will result in the less hospitalizations for heart failure as compared to performing just SC-guided therapy.

Conditions

  • Acute Heart Failure (AHF)

Interventions

PROCEDURE

CLINICAL ULTRASOUND

The intervention group will receive the standard care of treatment in AHF and the performance of CU.

Sponsors & Collaborators

  • Lara Palacios

    lead OTHER

Principal Investigators

  • LARA PALACIOS GARCIA, MD · Hospital Reina Sofia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2022-01-01
Completion
2022-03-01

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05042752 on ClinicalTrials.gov